by Clinical Neuropsychologist Online | Friday, October 9, 2026 | Dementia
Abstract INTRODUCTION Cerebral amyloid angiopathy (CAA) is characterized by impaired vascular amyloid-β clearance, distinct from Alzheimer’s disease (AD), underscoring the need to clarify its molecular basis for predicting therapy-related amyloid-related imaging...
by Clinical Neuropsychologist Online | Friday, October 9, 2026 | Dementia
Abstract INTRODUCTION Amyloid plaque deposition is a defining feature of Alzheimer’s disease (AD), yet how plaque-associated cellular alterations are reflected in noninvasive imaging remains unclear. METHODS We integrated high-resolution diffusion magnetic...
by Clinical Neuropsychologist Online | Friday, October 9, 2026 | Dementia
Abstract BACKGROUND Farming populations may face a disproportionate share of adverse exposures influencing Alzheimer’s disease (AD), yet farming data are rarely connected to cohorts with characterized AD neuropathology. Whether early-life exposure is related to...
by Clinical Neuropsychologist Online | Friday, October 9, 2026 | Neurorehabilitation
Neurorehabilitation and Neural Repair, Ahead of Print. Background:Walking performance is worse in Black than White adults with multiple sclerosis (MS), and that difference might extend into real-world, device-based measurements.Objective:The current study examined...
by Clinical Neuropsychologist Online | Friday, October 9, 2026 | Neurorehabilitation
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | October 9, 2026 Neuro-Rehab Previous Page
